UBS Group AG - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 143 filers reported holding VIKING THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,590,880
-37.5%
143,711
-8.5%
0.00%0.0%
Q2 2023$2,545,910
-18.3%
157,058
-16.1%
0.00%0.0%
Q1 2023$3,117,080
+620.1%
187,212
+306.6%
0.00%
Q4 2022$432,851
+286.5%
46,048
+12.1%
0.00%
Q3 2022$112,000
-8.2%
41,067
-2.9%
0.00%
Q2 2022$122,000
-46.7%
42,305
-44.6%
0.00%
Q1 2022$229,000
-85.0%
76,362
-77.0%
0.00%
Q4 2021$1,528,000
-10.2%
332,161
+22.7%
0.00%
-100.0%
Q3 2021$1,701,000
+69.1%
270,814
+61.2%
0.00%
Q2 2021$1,006,000
-47.9%
168,029
-45.0%
0.00%
-100.0%
Q1 2021$1,932,000
+304.2%
305,594
+260.0%
0.00%
Q4 2020$478,000
-75.6%
84,899
-74.8%
0.00%
-100.0%
Q3 2020$1,958,000
-17.9%
336,467
+1.7%
0.00%0.0%
Q2 2020$2,385,000
+30.5%
330,681
-15.4%
0.00%0.0%
Q1 2020$1,828,000
-44.4%
390,707
-4.7%
0.00%0.0%
Q4 2019$3,287,000
-17.6%
409,834
-29.3%
0.00%
-50.0%
Q3 2019$3,987,000
-14.8%
579,490
+2.7%
0.00%0.0%
Q2 2019$4,682,000
+72.9%
564,158
+107.1%
0.00%
+100.0%
Q1 2019$2,708,000
-30.5%
272,402
-46.5%
0.00%
-50.0%
Q4 2018$3,894,000
+8.4%
508,972
+146.9%
0.00%
+100.0%
Q3 2018$3,591,000
+360.4%
206,157
+150.8%
0.00%
Q2 2018$780,000
+181.6%
82,201
+29.8%
0.00%
Q1 2018$277,000
+575.6%
63,329
+533.3%
0.00%
Q4 2017$41,000
+485.7%
10,000
+121.9%
0.00%
Q1 2017$7,000
+75.0%
4,506
+38.6%
0.00%
Q2 2016$4,0000.0%3,252
+30.9%
0.00%
Q1 2016$4,000
-50.0%
2,485
+76.5%
0.00%
Q3 2015$8,0001,4080.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 450,900$2,624,0000.85%
Sio Capital Management, LLC 709,780$4,131,0000.82%
KNOTT DAVID M 218,102$1,269,0000.74%
ArrowMark Colorado Holdings LLC 7,988,635$46,494,0000.44%
Park West Asset Management LLC 1,457,507$8,483,0000.33%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 1,657$10,0000.18%
Virtus ETF Advisers LLC 42,507$247,0000.13%
Cornerstone Capital, Inc. 125,465$730,0000.10%
L & S Advisors Inc 114,988$669,0000.09%
EXANE DERIVATIVES 44,877$261,170,0000.08%
View complete list of VIKING THERAPEUTICS INC shareholders